CAMBRIDGE, Mass.--(BUSINESS WIRE)--Elixir Pharmaceuticals, Inc., announced today the appointment of Gregory D. Perry to the newly created position of Chief Financial Officer. In this position, Mr. Perry will be responsible for the development and execution of financial strategy, management of financial resources and financial operations. He will report directly to William Heiden, President and Chief Executive Officer of Elixir.
